REGENXBIO (RGNX)
(Delayed Data from NSDQ)
$11.69 USD
-0.81 (-6.48%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $11.80 +0.11 (0.94%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-1.16 | 0.00% |
Earnings Summary
For their last quarter, REGENXBIO (RGNX) reported earnings of -$1.05 per share, beating the Zacks Consensus Estimate of $-1.29 per share. This reflects a positive earnings surprise of 18.60%. Look out for RGNX's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$1.16 per share, reflecting a year-over-year increase of 17.73%.
Earnings History
Price & Consensus
Zacks News for RGNX
Regenxbio (RGNX) Reports Q2 Loss, Tops Revenue Estimates
RGNX: What are Zacks experts saying now?
Zacks Private Portfolio Services